Human response to Escherichia coli O157:H7 infection: Antibodies to secreted virulence factors

Infection and Immunity

Volumn 68, Issue 9, 2000, Pages 5090-5095

  Li, Y ^a   Frey, E ^a   Mackenzie, A M R ^a   Finlay, B B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; INTIMIN; VIRULENCE FACTOR;

ACUTE DIARRHEA; ACUTE PHASE RESPONSE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; PRIORITY JOURNAL; VACCINATION;

ADHESINS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; HUMANS; IMMUNOBLOTTING; RECEPTORS, CELL SURFACE; VIRULENCE;

EID: 0033860736     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.9.5090-5095.2000     Document Type: Article

References (26)

1. Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors
2. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome
3. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome
4. Escherichia coli O157:H7 infections - An emerging national health crisis, July 11-13 1994
5. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7, cleaves human coagulation factor V
6. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic-uremic syndrome
7. Interactions between enteropathogenic Escherichia coli and host epithelial cells
8. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection
9. Enteropathogenic and enterohaemorrhagic Escherichia coli: More subversive elements
10. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolyticuremic syndrome patients and healthy subjects
11. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome
12. Epidemiology of Shiga toxin-producing Escherichia coli in humans in the United States
13. Type III protein secretion systems in bacterial pathogens of animals and plants
14. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system
15. Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus
16. The nature of immunity to the Escherichia coli Shiga toxin and options for toxoid immunisation
17. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells
18. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells
19. Hemolytic-uremic syndrome: An analysis of the natural history and prognostic features
20. Detection of serum antibodies to the lipopolysaccharide of Escherichia coli O103 in patients with hemolytic-uremic syndrome
21. Role of Tit and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2
22. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12
23. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study
24. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor
25. Hemolytic uremic syndrome in childhood: Renal function ten years later
26. Protein translocation into host epithelial ceils by infecting enteropathogenic Escherichia coli